Group One Trading
EPIX

Group One Trading’s ESSA Pharma EPIX Stock Holding History

Group One Trading’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,823
Closed -$100K – 8577
2025
Q2 		$142K Buy
83,823
+62,705
+297% +$106K ﹤0.01% 4658
2025
Q1 		$33.4K Sell
21,118
-15,230
-42% -$25.8K ﹤0.01% 5476
2024
Q4 		$65.1K Buy
36,348
+8,553
+31% +$27.2K ﹤0.01% 4859
2024
Q3 		$168K Buy
+27,795
New +$153K ﹤0.01% 3778
2024
Q1 		– Sell
-11,175
Closed -$97.6K – 7261
2023
Q4 		$73.8K Sell
11,175
-30,685
-73% -$151K ﹤0.01% 4734
2023
Q3 		$129K Buy
41,860
+10,596
+34% +$30.5K ﹤0.01% 4212
2023
Q2 		$84.4K Buy
+31,264
New +$91.7K ﹤0.01% 4778
2023
Q1 		– Sell
-109
Closed -$320 – 7388
2022
Q4 		$275 Buy
+109
New +$313 ﹤0.01% 7013

Group One Trading's EPIX Position: Q3 2025 in Review

Group One Trading sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 83,823 shares — an estimated $100K sold.

Group One Trading first reported a position in EPIX in Q4 2022 and held it in 8 quarters. The position peaked at $168K in Q3 2024. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

  • Group One Trading reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 83,823 ESSA Pharma shares in Q3 2025, an estimated $100K.
  • Group One Trading first reported a position in ESSA Pharma in Q4 2022 and held it in 8 quarters.
  • Group One Trading's ESSA Pharma position peaked at $168K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.